Clinical Trials Browser

Phase 1 × Unknown × tositumomab I-131 × Clear all

NCT00022880 2005-06-24

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00022906 2005-06-24

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement

Phase 1 Unknown

Lymphoma, Non-Hodgkin